Howard W Robin sold $1.2M of Nektar Therapeutics (NKTR)

Executed Jun 16, disclosed Jun 18, 2 days later.

Value, as filed

$1.2M

20,000 sh across 4 lots

Executed

Jun 16

the trade date, as filed

Disclosed

Jun 18

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Howard W Robin President & CEO profile →

Howard W Robin (President & CEO) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Nektar Therapeutics (NKTR). The largest single filing was $1.2M of NKTR (20,000 sh across 4 lots, as filed), executed Jun 16.

The name

NKTR

Nektar Therapeutics NKTR · Healthcare · 7 filings in 24 months ticker →

Healthcare · Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in the field of immunotherapy in the Unit…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Howard W Robin in NKTR

NKTRSALE Nektar Therapeutics $120K
2,207 sh × $54.28
Exec Nov 25 2025
Filed Nov 25 2025 · 5:30 PM ET NKTRSALE Nektar Therapeutics $102K
2,156 sh × $47.49
Exec Sep 9 2025
Filed Sep 11 2025 · 5:30 PM ET NKTRSALE Nektar Therapeutics $125K
3,304 sh × $37.87
Exec Sep 5 2025
Filed Sep 8 2025 · 5:30 PM ET